Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Initial 25 IPOs on the Shanghai STAR Board Jump 140% Higher in First Session

publication date: Jul 23, 2019

On Monday, the first batch of young China high-tech companies soared higher as they began trading on Shanghai's brand-new STAR Exchange -- the first 25 companies to IPO on the exchange climbed an average of 140%. The most outstanding result was a 521% jump for Anji Microelectronics, a small semiconductor company, while the laggard of the group was able to muster "only" an 88% gain. Together the IPOs raised $5.2 billion for the 25 companies, about 20% more than expected. No biopharma companies were included in the initial group of STAR IPOs, though ChipScreen is scheduled for next week. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China